Navidea Biopharmaceuticals, Inc..
Follow Navidea Biopharmaceuticals, Inc.Navidea Biopharmaceuticals is a biopharmaceutical company focused on developing precision immunodiagnostic agents and immunotherapeutics. Its Manocept platform supports precision-targeted products intended to improve disease identification, diagnostic accuracy, clinical decision-making, and targeted treatment.[1]
Deals on Carrywatch
Every deal that names Navidea Biopharmaceuticals, Inc., and its role in each.
Meilleur Technologies, Inc. / Navidea Biopharmaceuticals, Inc.
Meilleur Technologies to purchase Navidea Alzheimer’s business assets
See deal detailsDeal Web
Navidea Biopharmaceuticals, Inc. and 0 firms it shares a posted deal with, and the path to any other firm.
Financials
5 fiscal years of figures as Navidea Biopharmaceuticals, Inc. reported them.
News
Loading headlines.
Sources
As of 24 Oct 2026.
- 01EX-99.1 Exhibit 99.1 Press Release
U.S. Securities and Exchange Commission · Researched 24 Oct 2026
- 02NAVB 2023-04-12 8-K
U.S. Securities and Exchange Commission · Researched 24 Oct 2026
Deal posts naming Navidea Biopharmaceuticals, Inc.:
- P01